Assessing Novel Drugs and Radiation Technology in the Chemoradiation of Oropharyngeal Cancer

Integrating immunotherapy, proton therapy and biological dose escalation into the definitive chemoradiation of oropharyngeal cancer poses several challenges. Reliable and reproducible data must be obtained in a timely fashion. However, despite recent international radiotherapy contouring guidelines,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cristaudo, Agostino, Hickman, Mitchell, Fong, Charles, Sanghera, Paul, Hartley, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163293/
https://www.ncbi.nlm.nih.gov/pubmed/29954154
http://dx.doi.org/10.3390/medicines5030065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163293/
https://www.ncbi.nlm.nih.gov/pubmed/29954154
http://dx.doi.org/10.3390/medicines5030065

Ejemplares similares